Commonwealth/State Highly Specialised Drugs Program, Victoria, Australia

Health Home

Main A to Z Index | Site Map | About Health | Links

>>contact

Contents	Program Information	Appendix 1 - AHMAC	Appendix 2 - Drugs Covered by the Program	Appendix 3 - Agreed Prices
Appendix 4 - Patient Eligibility Criteria	Appendix 5 - Certification	Appendix 6 - Community prescribers of AIDs & Hep C medications	Appendix 7 - Auditing Requirements	Appendix 8 - Claiming Procedures

Appendix 2: Drugs Covered by the Program - Page 8

Note: Drugs funded under the Highly Specialised Drugs Program provide a subsidy for community patients only. Inpatients remain the responsibility of the treating hospital.

Page 1 Abacavir Sulfate (Ziagen) to Baclofen (Lioresal Intrathecal)
Page 2 Bosentan Monohydrate (Tracleer)
Page 3 Cidofovir (Vistide) to Epoetin beta (NeoRecormon)
Page 4 Epoprostenol Sodium (Flolan)
Page 5 Etanercept (Enbrel) to Ibandronic Acid (Bondronat)
Page 6 Iloprost Trometamol (Ventavis) to Indinavir Sulphate (Crixivan)
Page 7 Infliximab (Remicade) to Sevelamer (Renagel)
Page 8 Sildenafil Citrate (Revatio)
Page 9 Sirolimus (Rapamune) to Zoledronic acid (Zometa)

Drug

Date Subsidised

PBAC Clinical Indications and other Restrictions

Sildenafil Citrate
(Revatio)

1 March 2007

Amended 1 April 2008

Amended 1 July 2008

Amended 1 August 2008

This drug needs prior approval by Medicare Australia.
More information and forms are available at www.medicare.gov.au/provider/pbs/drugs/index.shtml

Sildenafil Citrate - Amended August 2009 (PDF 128KB)

Page 9 >>

Return to Top

Contact: Michael Furey Tel (03) 9096 2506 Fax (03) 9096 9205

Last updated: 30 July, 2009
This web site is managed and authorised by the Ambulance & Acute Programs Section of the Metropolitan Health and Aged Care Services Division of the Victorian State Government, Department of Health, Australia

For general enquiries to the Department of Health telephone 61 3 90960000